Jun 12, 2013
Seegene participated in the International Congress of Chemotherapy and Infections (ICC) held in Yokohama, Japan on June 5-8, 2013 with its Japanese partner, EIDIA.
ICC is a biennial event, where approximately 5,000 professionals working in areas of infectious diseases all over the world participated. This year, it was co-hosted by the Asia-Pacific Society of Clinical Microbiology and Infection, the Japanese Association for Infectious Diseases, and the Japanese Society of Chemotherapy.
At this conference, Seegene introduced the TOCETM multiplex real-time PCR technology and its main products concerning major infectious diseases such as respiratory diseases, sexually transmitted infectious diseases, tuberculosis, pneumonia, cervical cancer, and the human papilloma virus.
